Erin Mistry Biography and Net Worth

EVP of CorMedix

Erin Mistry is EVP and Chief Commercial Officer, appointed in January 2023. She served as SVP Payer Strategy, Government Affairs and Trade from 2020 to 2022.  She leads the company’s commercial strategy and execution. Erin brings over 15 years of industry experience at the executive level from consulting to in-house executive management. Prior to joining CorMedix, Erin was Vice President of Market Access at Intarcia Therapeutics responsible for pricing, coverage, access, Real world evidence (RWE) and channel strategy for a competitive product in Type 2 Diabetes. Erin was also Senior Managing Director at Syneos Health where she was responsible for the global P&L of the Value Access Practice. In this capacity, Erin consulted on commercial strategy and market access with emerging, mid, and large biopharma across a broad range of therapeutic categories.   Erin holds an undergraduate and Masters degree in Biomechanical Engineering from North Carolina State University.

What is Erin Mistry's net worth?: The estimated net worth of Erin Mistry is at least $553.40 thousand as of October 31st, 2024. Mistry owns 52,011 shares of CorMedix stock worth more than $553,397 as of December 5th. This net worth evaluation does not reflect any other investments that Mistry may own. Additionally, Mistry receives a salary of $561,570.00 as EVP at CorMedix. Learn More about Erin Mistry's net worth.
How old is Erin Mistry?: Mistry is currently 41 years old. There are 3 older executives and no younger executives at CorMedix. The oldest executive at CorMedix is Mr. Joseph Todisco MBA, CEO & Director, who is 47 years old. Learn More on Erin Mistry's age.
What is Erin Mistry's salary?: As the EVP of CorMedix Inc, Mistry earns $561,570.00 per year. There are 2 executives that earn more than Mistry. The highest earning executive at CorMedix is Mr. Joseph Todisco MBA, CEO & Director, who commands a salary of $1,070,000.00 per year. Learn More on Erin Mistry's salary.
How do I contact Erin Mistry?: The corporate mailing address for Mistry and other CorMedix executives is 300 CONNELL DRIVE SUITE 4200, BERKELEY HEIGHTS NJ, 07922. CorMedix can also be reached via phone at (908) 517-9500 and via email at [email protected]. Learn More on Erin Mistry's contact information.
Has Erin Mistry been buying or selling shares of CorMedix?: Erin Mistry has not been actively trading shares of CorMedix during the last ninety days. Most recently, on Thursday, October 31st, Erin Mistry bought 1,500 shares of CorMedix stock. The stock was acquired at an average cost of $9.99 per share, with a total value of $14,985.00. Following the completion of the transaction, the executive vice president now directly owns 52,011 shares of the company's stock, valued at $519,589.89. Learn More on Erin Mistry's trading history.
Who are CorMedix's active insiders?: CorMedix's insider roster includes Elizabeth Hurlburt (EVP), Erin Mistry (EVP), and Joseph Todisco (CEO). Learn More on CorMedix's active insiders.
Are insiders buying or selling shares of CorMedix?: During the last twelve months, CorMedix insiders bought shares 1 times. They purchased a total of 25,000 shares worth more than $275,500.00. During the last twelve months, insiders at the sold shares 5 times. They sold a total of 163,997 shares worth more than $2,163,617.44. The most recent insider tranaction occured on October, 23rd when Director Myron Kaplan bought 25,000 shares worth more than $275,500.00. Insiders at CorMedix own 3.1% of the company. Learn More about insider trades at CorMedix.
Information on this page was last updated on 10/23/2025.

Erin Mistry Insider Trading History at CorMedix

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
10/31/2024	Buy	1,500	$9.99	$14,985.00	52,011

Erin Mistry Buying and Selling Activity at CorMedix

CorMedix Company Overview

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.

Today's Range

Now: $10.64

$10.27

$10.76

50 Day Range

MA: $10.79

$9.40

$12.16

2 Week Range

Now: $10.64

$5.60

$17.43

Volume

2,462,511 shs

Average Volume

2,952,876 shs

Market Capitalization

$838.33 million

P/E Ratio

5.17

Dividend Yield

N/A

Beta

1.32

Erin Mistry Biography and Net Worth

What is Erin Mistry's net worth?

How old is Erin Mistry?

What is Erin Mistry's salary?

How do I contact Erin Mistry?

Has Erin Mistry been buying or selling shares of CorMedix?

Who are CorMedix's active insiders?

Are insiders buying or selling shares of CorMedix?